LUX Infusion Bleeding Disorders

LUX Infusion is heading to the National Bleeding Disorders Conference 2026!

Every August, the bleeding disorders community comes together in one place to share stories, learn from each other, and push for better care — and this year, we're joining them in Orlando, FL, August 13–15.

Whether you're a patient, caregiver, advocate, or provider, we'd love to meet you. Stop by, say hello, or drop a comment below if you'll be there too.

See you in Orlando.

For people living with bleeding disorders, every infusion protects more than today. It protects tomorrow.

Staying consistent with treatment can help preserve joint health, reduce the risk of future complications, and give patients the confidence to keep living life on their own terms. That long-term perspective is at the heart of everything we do at LUX Infusion.

That's why consistent access to therapy and a care team you can rely on matters every step of the way.

At LUX Infusion, we're committed to making treatment as seamless as possible so patients can stay focused on living, not logistics.

Hepatitis C is now curable. For the bleeding disorders community, that sentence means something different.

Before the early 1990s, contaminated clotting factor concentrates passed HCV to a disproportionate number of patients. Not through any exposure they chose, but through the treatments keeping them alive.

This World Hepatitis Day, we reflect on how far we’ve come, honor those impacted, and recognize why closing the remaining treatment gaps still matters.

Among older generations of people with hemophilia, hepatitis C infection was tragically common. Not through any choice they made, but through the treatments that kept them alive.

This World Hepatitis Day, we honor that history and the community that has carried it with more resilience than most people will ever understand.

Today's treatment is a completely different story. Eight to twelve weeks of medication. A cure rate above 95%. If you or someone you know in the bleeding disorders community has never been tested or tried treatment in an earlier era and walked away, this day is a good moment to revisit that.

Living well with a bleeding disorder starts long before a bleed.

Managing a bleeding disorder isn't just about responding to bleeds—it's about staying one step ahead of them.

Routine treatment, regular check-ins, and a care team that understands your goals can help protect joint health, support an active lifestyle, and reduce complications over time.

At LUX Infusion, we're proud to partner with patients, families, and providers who believe proactive care makes all the difference.

Bleeding disorders do not pause between infusions. They are, by definition, chronic conditions managed over a lifetime.

This Chronic Disease Awareness Month, we want to recognize every patient who shows up for their health week after week because their condition requires it. Managing a bleeding disorder is about more than factor levels and bleed logs. It is about building a full life while navigating something that never entirely steps aside.

Joints are a lifelong conversation in the bleeding disorders community.

July is Juvenile Arthritis Awareness Month, and for many families in the bleeding disorders community, this one resonates.

Recurrent joint bleeds, even small ones, cause long-term damage that closely mirrors what is seen in inflammatory arthritis. For young patients managing hemophilia or VWD, protecting joint health is not just part of their treatment plan. It is one of its defining goals.

Our Points for Healthy Joints program is built around exactly that reality, helping young patients build the habits and support systems that protect joint health for years to come.

https://hubs.la/Q04p0Kxb0

The BD community does not take a summer break.

Managing a bleeding disorder is a year-round commitment. So is ours.

This summer, LUX Infusion stays dedicated to the bleeding disorders community through clinical support, advocacy partnerships, and the ongoing infusion care your patients depend on. Whether we are at conferences like FAAIS and IWAA, standing behind NBDF advocacy efforts, or making sure every patient stays on the therapy they need, our work continues.

To the patients, families, caregivers, and clinicians who show up for this community every day: we see you. We are honored to be part of your care team.

https://hubs.ly/Q04p1yJ50

Denecimig (Mim8) for Hemophilia A

New data published in the New England Journal of Medicine shows that denecimig, which “mimics” Factor VIII, significantly reduces bleeding for people with Hemophilia A, regardless of inhibitor status.

Participants experienced up to 99% fewer bleeds compared to on-demand treatment and 54% fewer than previous preventive factor therapies.

Between 64-95% of patients reported zero bleeds while on the study.

Success was shown in both once-weekly and once-monthly subcutaneous injections.

https://hubs.la/Q04jpZlP0

National HIV Testing Day is a significant moment for the bleeding disorders community. It is a time to honor a tragic history while also celebrating the rigorous clinical standards that have transformed the safety of our treatments.

LUX Infusion is committed to a “safety-first” culture that upholds the strict regulations needed to ensure that all plasma-based products are safe for you.

Visit our website to see how our patient-first approach is redefining the infusion experience.
https://hubs.la/Q04jpGV00
https://hubs.la/Q04jpFcf0